|
BOVILIS Coronavirus for Animal Use (Canada) - Drugs.com
Learn about BOVILIS Coronavirus for Animal Use (Canada) including: active ingredients, directions for use, precautions, and storage information.
Coronavirus - World Health Organization (WHO)
Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment. However, some will become seriously ill and require medical attention ...
Maternal, Newborn, Child and Adolescent Health and Ageing
We lead WHO’s work on the life course so that every pregnant woman, mother, newborn, child, adolescent, and older person will survive, thrive and enjoy health and well-being. This page includes information on pregnant women at higher risk of infection from COVID-19 ; protection against COVID-19 ...
An Update: Is hydroxychloroquine effective for COVID-19?
Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/. Accessed Feb. 2, 2021. FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems.
Coronavirus - World Health Organization (WHO)
Coronavirus Panorama general La enfermedad por coronavirus (COVID-19) es una enfermedad infecciosa causada por el virus SARS-CoV-2. La mayoría de las personas infectadas por el virus experimentarán una enfermedad respiratoria de leve a moderada y se recuperarán sin requerir un tratamiento especial. Sin embargo, algunas enfermarán gravemente y requerirán atención médica. Las personas ...
Strategic plan for coronavirus disease threat management: advancing ...
The WHO Strategic plan for coronavirus disease threat management sets out the global framework for the sustained, integrated and evidence-based management of coronavirus disease threats including COVID-19, MERS, and potential novel coronavirus diseases of public health importance, covering the 2025-2030 period. It emphasizes the long-term, routine management of coronavirus diseases, embedded ...
Call for public consultation – R&D roadmap for coronavirus medical ...
You are invited to review and provide expert input into a draft R&D Roadmap by 28 February 2026.
Coronavirus - World Health Organization (WHO)
Toutes les ressources en français de l'OMS sur les coronavirus.
Serology in the context of COVID-19
Serology can be used to accompany COVID-19 surveillance to measure the extent of infection in the population. However, uncertainty currently remains as to the performance of serologic tests in terms of sensitivity and specificity, and their ability to assess cross-reactivity with other coronaviruses such as common human coronaviruses, as well as SARS-CoV and MERS-CoV. The laboratory group at ...
Coronavirus disease (COVID-19)
COVID-19 is a disease caused by the SARS-CoV-2 coronavirus. There are a range of signs and symptoms, but hte most common symptoms reported for currently-circulating variants are fever, chills, and sore throat. Most people make a full recovery without needing treatment. People with severe disease or ...
|